Description
EMPIGET M 5/500mg, supplied in a convenient pack of 14 tablets, offers a foundational dual-action therapy for adults managing type 2 diabetes. Each tablet combines Empagliflozin 5mg, an SGLT2 inhibitor that helps kidneys excrete excess glucose from the body, with Metformin Hydrochloride 500mg, which works by reducing glucose production in the liver and improving the body’s sensitivity to insulin. This synergistic combination effectively lowers blood sugar levels. Beyond glycemic control, EMPIGET M 5/500mg also provides significant benefits by reducing the risk of cardiovascular death, hospitalization for heart failure, and the progression of chronic kidney disease in eligible patients. Used as an adjunct to diet and exercise, it offers comprehensive support for initiating or adjusting long-term diabetes management.
